MedTrace Logo

Antioxidant Supplements, Genetics and Chemotherapy Outcomes

NCT03413761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1771

Last updated 2022-08-08

No results posted yet for this study

Summary

This study will investigate the null hypothesis that use of antioxidant supplements during adjuvant chemotherapy will have no impact on toxicities and disease-free, as well as overall, survival, and also evaluate the role of polymorphisms in genes related to oxidative stress in relation to treatment outcomes.

Conditions

  • Node Positive Breast Cancer
  • Node Negative Breast Cancer

Sponsors & Collaborators

  • Roswell Park Cancer Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-18
Primary Completion
2013-11-12
Completion
2013-11-12

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413761 on ClinicalTrials.gov